TNGX Competitors & Alternatives
Compare Tango Therapeutics Inc with similar stocks in the same industry
Biotechnology
TNGX
Main Stock$30.03
Tradestie Score
56
Market Cap
$887.30M
Revenue Growth
-1.0%
Analyst Upside
+6.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
QURE
uniQure N.V.
|
$26.95
|
$3.39B | - | 55 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.37
|
$3.33B | - | 55 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$31.17
|
$3.31B | - | 51 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$22.78
|
$3.09B | - | 61 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$29.10
|
$3.08B | - | 53 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.66
|
$3.03B | - | 58 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$51.31
|
$3.02B | - | 57 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$54.18
|
$3.01B | - | 53 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
More TNGX Analysis
Data updated: Jun 08, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry